InnovaRx Innova Health Strategies

E65

Localized adiposity

Billable FY2026 2025-10-01 → 2026-09-30
Exclusions 1 never code together
E00-E89chapter
Excludes1
  • transitory endocrine and metabolic disorders specific to newborn (P70-P74)P70-P74

Excludes1 — never code together. The excluded condition and this one are mutually exclusive.

Instructional notes 2
E65code
Inclusion terms
  • Fat pad
E00-E89chapter
Notes
  • All neoplasms, whether functionally active or not, are classified in Chapter 2. Appropriate codes in this chapter (i.e. E05.8, E07.0, E16-E31, E34.-) may be used as additional codes to indicate either functional activity by neoplasms and ectopic endocrine tissue or hyperfunction and hypofunction of endocrine glands associated with neoplasms and other conditions classified elsewhere.E05.8E07.0E16-E31E34.-
Index entries leading here 8
  • Pannus (allergic) (cornea) (degenerativus) (keratic) H16.42
    • abdominal (symptomatic) E65
  • Adiposity — see also Obesity
    • localized E65
  • Fatty — see also condition
  • Excess, excessive, excessively
    • fat — see also Obesity
      • localized E65
  • Fat
  • Hypertrophy, hypertrophic
  • Redundant, redundancy
    • panniculus (abdominal) E65
  • Panniculus adiposus (abdominal) E65
Additional references
AHA Coding Clinic® Licence required

Official coding advice for this code. Published by the American Hospital Association. Not included in this installation.

Risk adjustment

Maps to no condition category in any loaded model.

Presence is a property of the code. Untick a model to hide it everywhere.

This code

Billable
yes
Code set
FY2026
Block
E65-E68

Present FY2024–FY2027.